Literature DB >> 3182996

Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources.

L A Carson1, O C Tablan, L B Cusick, W R Jarvis, M S Favero, L A Bland.   

Abstract

Pseudomonas cepacia has recently emerged as an important pathogen affecting cystic fibrosis (CF) patients. We evaluated three selective media to assess their comparative potential for identification of patients colonized with P. cepacia and for efficacy of detection of P. cepacia in environmental fluids. Test organisms included P. cepacia isolates from CF patients (10 each from two CF centers), non-CF patients (10 isolates), and environmental sources (10 isolates). Microbiologic assays were done by the membrane filter procedure; filters were placed on P. cepacia medium (PCM), OFPBL, TB-T, MacConkey agar (MAC), and blood agar (BA) or Standard Methods (SM) sugar, and colonies were counted after incubation at 30 or 35 degrees C for 72 h. Mean recovery efficiencies (MREs) (mean CFU/ml on selective media compared with CFU/ml on BA controls) for environmental and non-CF P. cepacia and patient isolates from one CF center showed a rank order of PCM greater than OFPBL greater than TB-T; for isolates from a second CF center, a rank order of PCM greater than TB-T greater than OFPBL was obtained. MREs for CF center isolates were generally lower than for non-CF patients or environmental isolates on P. cepacia-selective media. With MAC, the MREs for each group of CF isolates were extremely low (14 and 2%) compared with those for non-CF patient (47%) or environmental (84%) isolates. In laboratory and field studies, PCM and OFPBL showed good selectivity against bacteria commonly associated with CF patient respiratory secretions. These findings show that selective media should be used in clinical settings where P. cepacia is sought. With environmental fluids from CF centers, P. cepacia-selective media showed low selectivity against a variety of gram-negative water bacteria and appeared to afford little advantage over SM agar for isolating P. cepacia from environmental samples.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182996      PMCID: PMC266823          DOI: 10.1128/jcm.26.10.2096-2100.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Effects of overnight refrigeration on the microscopic evaluation of sputum.

Authors:  R L Penn; R Silberman
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

2.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

3.  Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis.

Authors:  M J Thomassen; C A Demko; C F Doershuk; R C Stern; J D Klinger
Journal:  Am Rev Respir Dis       Date:  1986-10

4.  Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.

Authors:  P H Gilligan; P A Gage; L M Bradshaw; D V Schidlow; B T DeCicco
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

5.  Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis.

Authors:  D F Welch; M J Muszynski; C H Pai; M J Marcon; M M Hribar; P H Gilligan; J M Matsen; P A Ahlin; B C Hilman; S A Chartrand
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

6.  Selective medium for Pseudomonas cepacia containing 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan and polymyxin B sulfate.

Authors:  B J Wu; S T Thompson
Journal:  Appl Environ Microbiol       Date:  1984-10       Impact factor: 4.792

7.  Comparison of two selective media developed to isolate Pseudomonas cepacia from patients with cystic fibrosis.

Authors:  C Black-Payne; M B Lierl; J A Bocchini; B C Hilman; E D Rambin; R Silberman
Journal:  Diagn Microbiol Infect Dis       Date:  1987-04       Impact factor: 2.803

8.  Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist.

Authors:  M J Thomassen; C A Demko; J D Klinger; R C Stern
Journal:  Am Rev Respir Dis       Date:  1985-05

9.  Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.

Authors:  O C Tablan; T L Chorba; D V Schidlow; J W White; K A Hardy; P H Gilligan; W M Morgan; L A Carson; W J Martone; J M Jason
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406

10.  Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis.

Authors:  O C Tablan; L A Carson; L B Cusick; L A Bland; W J Martone; W R Jarvis
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

View more
  13 in total

Review 1.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Microbiological processing of respiratory specimens from patients with cystic fibrosis.

Authors: 
Journal:  Can J Infect Dis       Date:  1993-05

3.  Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis.

Authors:  Juyan Zhou; Elizabeth Garber; Manisha Desai; Lisa Saiman
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  Evaluation of liquid and solid culture media for the recovery and enrichment of Burkholderia cenocepacia from distilled water.

Authors:  Youngbeom Ahn; Jeong Myeong Kim; Hyeri Ahn; Yong-Jin Lee; John J LiPuma; David Hussong; Carl E Cerniglia
Journal:  J Ind Microbiol Biotechnol       Date:  2014-04-23       Impact factor: 3.346

5.  An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis.

Authors:  A Holmes; R Nolan; R Taylor; R Finley; M Riley; R Z Jiang; S Steinbach; R Goldstein
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

6.  Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia.

Authors:  M L Vasil; D P Krieg; J S Kuhns; J W Ogle; V D Shortridge; R M Ostroff; A I Vasil
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

7.  Selective media for isolation of Burkholderia (Pseudomonas) cepacia from the respiratory secretions of patients with cystic fibrosis.

Authors:  N Cimolai; C Trombley; A G Davidson; L T Wong
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

Review 8.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

9.  Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis.

Authors:  G V Doern; B Brogden-Torres
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

Review 10.  Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?

Authors:  A Holmes; J Govan; R Goldstein
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.